 Micah Donovan
Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 3 | 2024 | 481 | 1.290 |
Why?
| | Erythropoiesis | 1 | 2024 | 51 | 0.900 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2024 | 43 | 0.890 |
Why?
| | Heme | 1 | 2024 | 77 | 0.880 |
Why?
| | Cyclin-Dependent Kinases | 2 | 2022 | 130 | 0.800 |
Why?
| | BRCA1 Protein | 2 | 2019 | 65 | 0.790 |
Why?
| | Gene Expression Profiling | 2 | 2024 | 1706 | 0.670 |
Why?
| | Breast Neoplasms | 4 | 2020 | 2142 | 0.670 |
Why?
| | Genistein | 1 | 2019 | 14 | 0.660 |
Why?
| | Epigenesis, Genetic | 3 | 2019 | 613 | 0.610 |
Why?
| | DNA Methylation | 3 | 2020 | 607 | 0.600 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2018 | 51 | 0.580 |
Why?
| | RNA | 1 | 2024 | 883 | 0.550 |
Why?
| | Hypoxia | 1 | 2024 | 1084 | 0.550 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2019 | 1356 | 0.450 |
Why?
| | Neoplasms | 3 | 2023 | 2470 | 0.440 |
Why?
| | Transcriptome | 3 | 2024 | 887 | 0.430 |
Why?
| | Signal Transduction | 2 | 2024 | 4925 | 0.430 |
Why?
| | Diet, High-Fat | 3 | 2021 | 239 | 0.360 |
Why?
| | Diet | 1 | 2018 | 1213 | 0.340 |
Why?
| | Colon | 2 | 2021 | 254 | 0.290 |
Why?
| | Janus Kinase Inhibitors | 1 | 2024 | 25 | 0.230 |
Why?
| | Erythropoietin | 1 | 2024 | 86 | 0.210 |
Why?
| | Piperidines | 1 | 2024 | 199 | 0.210 |
Why?
| | Cyclin C | 1 | 2022 | 2 | 0.210 |
Why?
| | Cyclins | 1 | 2022 | 89 | 0.200 |
Why?
| | Linoleic Acid | 2 | 2020 | 41 | 0.200 |
Why?
| | Bile Acids and Salts | 2 | 2020 | 195 | 0.190 |
Why?
| | Mediator Complex | 1 | 2022 | 57 | 0.190 |
Why?
| | Child, Preschool | 3 | 2024 | 10517 | 0.180 |
Why?
| | Sequence Analysis, RNA | 1 | 2024 | 429 | 0.180 |
Why?
| | Pyrimidines | 1 | 2024 | 459 | 0.180 |
Why?
| | Stress, Physiological | 1 | 2024 | 413 | 0.180 |
Why?
| | Dietary Fats | 2 | 2020 | 301 | 0.180 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.170 |
Why?
| | RNA-Binding Proteins | 2 | 2020 | 388 | 0.170 |
Why?
| | Proteome | 1 | 2024 | 443 | 0.160 |
Why?
| | Dysbiosis | 1 | 2021 | 169 | 0.160 |
Why?
| | Animal Feed | 1 | 2019 | 50 | 0.160 |
Why?
| | Mice | 5 | 2024 | 16937 | 0.160 |
Why?
| | Female | 8 | 2024 | 68776 | 0.160 |
Why?
| | Sodium Compounds | 1 | 2019 | 4 | 0.160 |
Why?
| | Arsenites | 1 | 2019 | 5 | 0.160 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2023 | 511 | 0.150 |
Why?
| | Flavonoids | 1 | 2018 | 78 | 0.150 |
Why?
| | Tamoxifen | 1 | 2019 | 200 | 0.140 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2019 | 158 | 0.140 |
Why?
| | Humans | 11 | 2024 | 129650 | 0.140 |
Why?
| | Estrogen Receptor alpha | 1 | 2019 | 133 | 0.140 |
Why?
| | Epigenomics | 1 | 2018 | 110 | 0.140 |
Why?
| | Mice, Transgenic | 2 | 2020 | 2119 | 0.140 |
Why?
| | Risk | 1 | 2020 | 854 | 0.140 |
Why?
| | Adolescent | 3 | 2024 | 20393 | 0.140 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2019 | 197 | 0.130 |
Why?
| | Animals | 7 | 2024 | 35361 | 0.130 |
Why?
| | Colonic Neoplasms | 1 | 2019 | 243 | 0.130 |
Why?
| | Child | 3 | 2024 | 20883 | 0.130 |
Why?
| | Cell Survival | 1 | 2019 | 1086 | 0.130 |
Why?
| | T-Lymphocytes | 1 | 2022 | 1928 | 0.110 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2019 | 759 | 0.110 |
Why?
| | Intestinal Mucosa | 1 | 2019 | 590 | 0.110 |
Why?
| | Gastrointestinal Microbiome | 1 | 2021 | 641 | 0.110 |
Why?
| | Adult | 3 | 2024 | 35576 | 0.110 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3215 | 0.100 |
Why?
| | Male | 5 | 2024 | 63681 | 0.090 |
Why?
| | Inflammation | 1 | 2019 | 2736 | 0.070 |
Why?
| | Obesity | 1 | 2020 | 2883 | 0.070 |
Why?
| | Mice, Inbred C57BL | 3 | 2021 | 5440 | 0.060 |
Why?
| | Transcription Factors | 2 | 2023 | 1651 | 0.060 |
Why?
| | Pyrroles | 1 | 2024 | 202 | 0.050 |
Why?
| | Cyclin-Dependent Kinase 8 | 1 | 2022 | 44 | 0.050 |
Why?
| | Gene Silencing | 1 | 2023 | 190 | 0.050 |
Why?
| | Cecum | 1 | 2020 | 32 | 0.040 |
Why?
| | Transcriptional Activation | 1 | 2023 | 366 | 0.040 |
Why?
| | Transgenes | 1 | 2020 | 177 | 0.040 |
Why?
| | Microfilament Proteins | 1 | 2020 | 129 | 0.040 |
Why?
| | Genetic Testing | 1 | 2022 | 428 | 0.040 |
Why?
| | Immunotherapy, Adoptive | 1 | 2022 | 295 | 0.040 |
Why?
| | Genes, jun | 1 | 2019 | 9 | 0.040 |
Why?
| | Fetal Research | 1 | 2019 | 3 | 0.040 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2019 | 20 | 0.040 |
Why?
| | Folate Receptor 1 | 1 | 2019 | 15 | 0.040 |
Why?
| | Autoimmunity | 1 | 2024 | 862 | 0.040 |
Why?
| | Cyclin D1 | 1 | 2019 | 63 | 0.040 |
Why?
| | MCF-7 Cells | 1 | 2019 | 116 | 0.040 |
Why?
| | Blotting, Western | 1 | 2021 | 1205 | 0.040 |
Why?
| | Cyclooxygenase 2 | 1 | 2019 | 177 | 0.040 |
Why?
| | Mice, Nude | 1 | 2019 | 683 | 0.030 |
Why?
| | Autoantibodies | 1 | 2024 | 1466 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 611 | 0.030 |
Why?
| | Cytokines | 1 | 2024 | 2017 | 0.030 |
Why?
| | Colitis | 1 | 2019 | 242 | 0.030 |
Why?
| | Body Weight | 1 | 2020 | 940 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 814 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2022 | 1333 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1472 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2023 | 1902 | 0.030 |
Why?
| | Environmental Exposure | 1 | 2019 | 462 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2019 | 1207 | 0.030 |
Why?
| | Liver | 1 | 2020 | 1839 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2019 | 4083 | 0.020 |
Why?
| | Infant | 1 | 2024 | 9024 | 0.020 |
Why?
| | Young Adult | 1 | 2024 | 12426 | 0.020 |
Why?
| | Middle Aged | 1 | 2024 | 31154 | 0.010 |
Why?
|
|
Donovan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|